Ivonescimab 10 mg/kg

DRUG2 trials

Sponsors

PrECOG, LLC., Groupe Oncologie Radiotherapie Tete et Cou

Conditions

Extensive Stage Lung Small Cell CancerSquamous Cell Carcinoma Head and Neck Cancer (HNSCC)

Phase 2

Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

RecruitingNCT07057791

PrECOG, LLC.Extensive Stage Lung Small Cell Cancer

Start: 2026-02-01End: 2030-01-01Target: 60Updated: 2026-01-27

Phase 3

Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment of SCCHN

Not yet recruitingNCT07264075

Groupe Oncologie Radiotherapie Tete et CouSquamous Cell Carcinoma Head and Neck Cancer (HNSCC)

Start: 2026-04-01End: 2030-05-01Target: 780Updated: 2026-04-02